Lisanti Capital Growth’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Lisanti Capital Growth’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-65,750	Closed	-$818K	–	132
2016 Q4	$818K	Buy	65,750 +35,205	+115%	+$424K	0.99%	47
2016 Q3	$418K	Sell	30,545 -26,470	-46%	-$266K	0.53%	81
2016 Q2	$421K	Buy	+57,015	New	+$428K	0.64%	73

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Lisanti Capital Growth's ARIA Position: Q1 2017 in Review

Lisanti Capital Growth sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 65,750 shares — an estimated $818K sold.

Lisanti Capital Growth first reported a position in ARIA in Q2 2016 and held it in 3 quarters. The position peaked at $818K in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Lisanti Capital Growth reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Lisanti Capital Growth sold 65,750 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $818K.
Lisanti Capital Growth first reported a position in Ariad Pharmaceuticals Inc in Q2 2016 and held it in 3 quarters.
Lisanti Capital Growth's Ariad Pharmaceuticals Inc position peaked at $818K in Q4 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Lisanti Capital Growth's 13F filing for Q1 2017, filed 12 May 2017.